- Treatment Effect of Combining Lenvatinib and Vemurafenib for BRAF Mutated Anaplastic Thyroid Cancer
-
Hong CM, Oh JM, Gangadaran P, Rajendran RL, Ahn BC
- KMID: 2522917
- Int J Thyroidol.
- 2021 Nov;14(2):127-134.
- doi: 10.11106/ijt.2021.14.2.127
Background and Objectives: Even though most of the thyroid cancer shows good prognosis, de-differentiated thyroid cancer is still refractory to conventional treatments. Recently, kinase inhibitors including multi-kinase and BRAF inhibitors... -
- CITED
-
- Close
- SHARE
-
- Close
